Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Japanese phase II study of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma.

Authors
Type
Published Article
Journal
Cancer science
Publication Date
Volume
100
Issue
1
Pages
158–164
Identifiers
DOI: 10.1111/j.1349-7006.2008.00999.x
PMID: 19018755
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments